EMEA-000827-PIP01-09-M04

Key facts

Invented name
Cayston
Active substance
Aztreonam
Therapeutic area
Infectious diseases
Decision number
P/0064/2016
PIP number
EMEA-000827-PIP01-09-M04
Pharmaceutical form(s)
Powder and solvent for nebuliser solution
Condition(s) / indication(s)
Treatment of Pseudomonas aeruginosa pulmonary infection / colonisation in patients with cystic fibrosis
Route(s) of administration
Inhalation use
Contact for public enquiries
Gilead Sciences International Limited
United Kingdrom
Tel. +44 (0)1223 897300
Fax +44 (0)1223 897284
E-mail: regulatory.pip@gilead.com
Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating
Average
1 rating